Surmodics (SRDX)
(Delayed Data from NSDQ)
$39.12 USD
-0.22 (-0.56%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $39.14 +0.02 (0.05%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 28% (70 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.50 | 1.69 | 9.99 |
Current Quarter Estimate | -0.27 | 7.55 | 61.00 |
Year Ago Quarter Estimate | 0.53 | 4.52 | 54.84 |
Next Quarter Estimate | -0.08 | 8.31 | 63.00 |
Next Year Estimate | 0.15 | 45.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -393.75 | 12.70 | 15.67 |
Next Year | 131.91 | 22.20 | 11.34 |
Last 5 Years | -22.90 | 2.90 | 8.10 |
Next 5 Years | NA | 15.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 118.54 | 4.88 |
Price/Book (MRQ) | 4.72 | 2.24 |
Price/Cash Flow (MRFY) | 49.89 | 11.85 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1.16% | -9.36% |
Return on Equity (TTM) | 3.88% | -2.30% |
Debt to Equity (MRQ) | 0.25 | 22.47 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.